Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01280825 · ClinicalTrials.gov registry record
The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
A clinical trial of Hepatitis C and Heart Diseases, sponsored by University of Chicago.
- Recruiting
- Registry status
- 1,200
- Enrollment target
- 1
- Study location
NCT01280825: Recruiting study of Hepatitis C and Heart Diseases, sponsored by University of Chicago.
NCT01280825 is a study of Hepatitis C and Heart Diseases that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 1,200 participants, below the 1,879-participant average among 106 other Hepatitis C trials with a reported enrollment target (36% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01280825, a study of Hepatitis C and Heart Diseases, is actively recruiting participants, sponsored by University of Chicago.
- RECRUITING
- Registry status
- 1,200 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to collect DNA samples from patients undergoing routine care at the University of Chicago. These samples will be tested for differences in genes that may suggest greater risk of side effects or chance of increased benefit from certain medications. The results will be made available to the patient's treating physician and the researchers will track whether or not this information is used in routine health care.
Conditions Studied
Study Locations (1)
Illinois
- University of Chicago Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,200 participants |
| Start Date | 2011-01-14 |
| Est. Completion | 2027-12-14 |
What NCT01280825 shows while recruiting
NCT01280825 is an observational study that tracks outcomes without assigning an intervention. Its 1,200 participants enrollment target places it among the larger protocols in the corpus, below the 1,879-participant average among 106 other Hepatitis C trials with a reported enrollment target (36% lower).
The record links to 8 conditions, with Hepatitis C appearing as the primary indexed condition, and to 0 interventions.
NCT01280825 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT01280825 about?
NCT01280825 is a clinical study titled "The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing". The purpose of this study is to collect DNA samples from patients undergoing routine care at the University of Chicago. These samples will be tested for differences in genes that may suggest greater risk of side effects or chance of increased benefit from certain medications. The results will be mad...
What is the current status of trial NCT01280825?
This trial is currently recruiting. The enrollment target is 1,200 participants. The study started on 2011-01-14. Estimated completion is 2027-12-14.
What conditions does trial NCT01280825 study?
This clinical trial studies the following conditions: Hepatitis C, Heart Diseases, Inflammatory Bowel Diseases, Autoimmune Disease, Blood Coagulation Disorders.
Who is sponsoring clinical trial NCT01280825?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01280825 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hepatitis C
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01280825's enrollment target sits among peer trials
1,200 5th of 106 higher than 102 of 106 other Hepatitis C trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hepatitis C trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
DBS TaT in Peer-assisted Telemedicine for Hepatitis C
RECRUITING · NA
-
Evaluation of Patients With Liver Disease
RECRUITING
-
The HOPE Study: Characterizing Patients With Hepatitis B and C
RECRUITING
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
RECRUITING · NA
-
Partner Navigation Intervention for Hepatitis C Treatment Among Young People Who Inject Drugs
RECRUITING · NA
-
The Treatment in Pregnancy for Hepatitis C ("TiP-HepC") Registry
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001987 · 1,200 participants
Genetic Studies of Insulin and Diabetes
- NCT00477100 · 1,200 participants
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
- NCT01209000 · 1,200 participants
Nephrotic Syndrome Study Network
- NCT01944332 · 1,200 participants · NA
Gamete Treatment to Correct Fertilization Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI